COOPER COMPANIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data COOPER COMPANIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,967	2,139	2,533	2,653	2,431	2,923	3,308	3,593	3,895	4,092
Cost of revenue	794	773	901	897	896	967	1,169	1,235	1,300	1,410
Gross profit	1,173	1,366	1,632	1,757	1,535	1,956	2,140	2,358	2,596	2,682
Research and development	65.4	69.2	84.8	86.7	93.3	92.7	110	137	155	172
Selling, general and administrative	723	799	973	996	993	1,211	1,342	1,501	1,534	1,628
Operating income	324	429	403	547	312	506	508	533	706	683
Interest expense	26.2	33.4	82.7	68	36.8	23.1	57.3	105	114	100
Other non-operating income	-2.3	-1.7	11.5	-1.3	-8.5	8.8	25	-14.9	-9.1	-16.4
Pre-tax income	296	394	332	477	267	492	475	413	582	567
Income tax	20.7	21.1	192	10.7	28.1	-2,453	89.5	119	190	192
Net income to minority interests	1	0	0
Net income	274	373	140	467	238	2,945	386	294	392	375
EBITDA	522	618	678	828	462	815	854	901	1,081	1,060
EPS, basic	1.41	1.91	0.71	2.36	1.21	14.95	1.95	1.49	1.97	1.88
EPS, diluted	1.40	1.88	0.70	2.33	1.20	14.79	1.94	1.48	1.96	1.87
Shares, basic (weighted)	194	196	196	198	196	197	197	198	199	199
Shares, diluted (weighted)	196	198	199	200	198	199	199	199	200	200
Dividend per share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	101	88.8	77.7	89	116	95.9	138	121	108	111
Receivables	291	317	375	435	435	515	558	610	717	829
Inventory	418	454	469	507	570	586	629	736	803	846
Other current assets	77.5	93.7	170	132	153	179	209	239	324	321
Total current assets	937	953	1,091	1,163	1,274	1,465	1,534	1,705	1,952	2,106
Property, plant and equipment	878	910	976	1,132	1,282	1,348	1,414	1,629	1,861	2,080
Lease right-of-use assets					260	257	230	242	261	271
Goodwill	2,165	2,355	2,392	2,429	2,447	2,574	3,610	3,625	3,838	3,853
Intangible assets	441	505	1,521	1,405	1,289	1,272	1,885	1,710	1,791	1,586
Other non-current assets	51.9	75.6	74.1	66.8	105	401	588	637	661	689
Total assets	4,479	4,859	6,113	6,275	6,738	9,606	11,492	11,659	12,315	12,395
Accounts payable	107	142	146	150	176	161	249	262	261	300
Accrued liabilities	77.7	84.1	94	105	119	149	152	175	175	211
Deferred revenue						19	93.6	124	130	128
Short-term debt	211	0	37.1	564	409	83.4	413	45.4	33.3	47.8
Total current liabilities	543	396	537	1,111	1,004	732	1,280	969	1,023	1,113
Long-term debt	1,107	1,149	1,986	1,263	1,384	1,396	2,347	2,520	2,548	2,456
Lease liabilities					237	232	206	216	231	241
Other non-current liabilities							225	239	312	283
Total liabilities	1,783	1,683	2,805	2,646	2,913	2,664	4,318	4,108	4,232	4,156
Total debt	1,318	1,149	1,986	1,263	1,384	1,396	2,347	2,520	2,548	2,456
Paid-in capital	1,494	1,527	1,572	1,615	1,647	1,715	1,766	1,817	1,921	1,976
Retained earnings	2,046	2,434	2,576	3,026	3,262	6,202	6,585	6,876	7,268	7,643
Treasury stock	-360	-415	-415	-571	-617	-640	-715	-710	-706	-995
Other comprehensive income	-490	-375	-431	-447	-472	-341	-467	-454	-422	-407
Shareholders' equity	2,696	3,176	3,308	3,628	3,825	6,942	7,175	7,551	8,083	8,239
Minority interests	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Total equity	2,696	3,176	3,308	3,629	3,825	6,942	7,175	7,551	8,084	8,239
Total liabilities and equity	4,479	4,859	6,113	6,275	6,738	9,606	11,492	11,659	12,315	12,395
Shares outstanding					196	197	49.3	198	200	196

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	275	373	140	467	238	2,945	386	294	392	375
Depreciation and amortization	198	188	275	281	150	309	346	368	375	377
Stock-based compensation	29.9	37.2	43.2	35.1	37.6	43.8	54.2	62.1	75.1	70.5
Deferred income tax	-10.7	-7.1	2.9	-15.9	-0.9	-2,502	53.9	44.7	119	135
Change in receivables	1.6	-25.1	-59.5	-55.6	8.5	-75.5	-33.8	-60.2	-117	-120
Change in inventory	12.2	-30.9	-5	-37.3	-62.3	-9.2	-40.4	-105	-59.3	-46
Change in payables	-10.5	25	2.9	3.6	23.2	-16	49.9	5.5	9.3	8
Cash from operations	510	594	669	713	487	739	692	608	709	796
Capital expenditures	-153	-127	-194	-292	-310	-214	-242	-393	-421	-362
Cash from investing	-419	-381	-1,518	-351	-365	-450	-1,831	-449	-765	-373
Debt issued	1,577	1,414	2,748	1,137	3,200	1,427	1,511	2,124	3,524	3,111
Debt repaid	-1,460	-1,365	-1,912	-1,862	-3,236	-1,416	-562	-1,954	-3,507	-3,205
Share buybacks	0	-55	0	-156	-47.8	-24.8	-78.5	0	0	-290
Dividends paid	-2.9	-2.9	-2.9	-3	-3	-3	-3	-3	0	0
Cash from financing	-1.4	-228	844	-351	-95.5	-311	1,194	-174	39.2	-426
Exchange rate effect	-5.1	3.6	-4.4	-1.2	0.7	2.9	-12.9	-2.3	2.9	5.6
Net change in cash	84.4	-12	-8.6	9.3	27.3	-20.2	42	-17.7	-13.2	2.9
Free cash flow	357	466	475	421	176	524	450	215	288	434
Interest paid	23.7	31.3	82.1	75.3	46.5	28.4	49.1	118	135	115
Income taxes paid	29.4	15.6	18.8	39.2	51.1	63.2	66.6	67.8	78.4	100

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $55.38 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	65.9%	Gross profit / revenue.
Operating margin	12.8%	Operating income / revenue.
EBITDA margin	19.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.9%	Pre-tax income / revenue.
Net margin	13.5%	Net income / revenue.
FCF margin	16.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	24.4%	Cash from operations / revenue.
Effective tax rate	-23.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	6.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	4.5%	Net income / average total assets.
Return on invested capital (ROIC)	4.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	4.0%	Research and development expense / revenue.
SG&A / revenue	44.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	8.4%	Capital expenditures / revenue.
D&A / revenue	6.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	7.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	7.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-3.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	10.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	17.0%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-1.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	7.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	18.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-4.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-1.0%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	9.5%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-4.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-1.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	9.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	12.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	4.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	50.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-1.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	19.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	16.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	13.0%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.22x	Current assets / current liabilities.
Quick ratio	0.51x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.08x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.23x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.1%	Total debt / total assets.
Liabilities / assets	34.3%	Total liabilities / total assets.
Net debt	$1.76B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.11x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	6.10x	Operating income / interest expense.
Working capital	$414.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	42.0%	(Goodwill + intangible assets) / total assets.
Tangible book value	$3.01B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.33x	Revenue / average total assets.
Fixed asset turnover	1.98x	Revenue / average property, plant and equipment.
Inventory turnover	1.58x	Cost of revenue / average inventory.
Days inventory	230 days	365 x average inventory / cost of revenue.
Receivables turnover	5.37x	Revenue / average receivables.
Days sales outstanding	68 days	365 x average receivables / revenue.
Days payables	64 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	235 days	Days inventory + days sales outstanding - days payables.
FCF conversion	118.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	34.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.95	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$21.91	Revenue / diluted weighted shares.
FCF per share	$3.51	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.34	Cash from operations / diluted weighted shares.
Book value per share	$43.81	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$15.81	Tangible book value / shares outstanding.
Cash per share	$0.81	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	95.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$10.80B	Share price x shares outstanding.
Enterprise value	$12.56B	Market cap + total debt - cash - short-term investments.
P/E	18.9x	Market cap / net income. Only when net income is positive.
P/S	2.55x	Market cap / revenue.
P/B	1.30x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.59x	Market cap / tangible book value, when positive.
P/FCF	15.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.5x	Market cap / cash from operations, when positive.
EV/Sales	2.96x	Enterprise value / revenue.
EV/EBIT	23.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	15.1x	Enterprise value / EBITDA, when both are positive.
EV/FCF	18.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.3%	Free cash flow / market cap.
Earnings yield	5.3%	Net income / market cap (the inverse of P/E).
Shareholder yield	6.0%	(Dividends paid + share buybacks) / market cap.

What was COOPER COMPANIES, INC.'s revenue in fiscal 2025?

COOPER COMPANIES, INC. reported revenue of $4.09B for fiscal 2025, 5.1% higher than the year before.

Was COOPER COMPANIES, INC. profitable in fiscal 2025?

Yes. Net income was $374.9M, a net margin of 9.2%.

How much free cash flow did COOPER COMPANIES, INC. generate in fiscal 2025?

Cash from operations of $796.1M minus capital expenditures of $362.4M left free cash flow of $433.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to COOPER COMPANIES, INC.